Study Summary
This trial is testing whether adding misoprostol to vasopressin decreases blood loss, compared to vasopressin alone. The study will be double-blinded, meaning neither the patient nor researcher will know who gets the placebo or misoprostol. Outcomes such as decreased hemoglobin and hematocrit, transfusion need, and operative time will be measured to see if misoprostol makes a significant difference. Patients will also be monitored for any side effects from misoprostol.
- Myomectomy
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 24 hours postop
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Misoprostol 100Mcg Tab
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
50 Total Participants · 2 Treatment Groups
Primary Treatment: Misoprostol 100Mcg Tab · Has Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 20 - 50 · Female Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are senior citizens eligible to take part in this trial?
"This research is suitable for those aged between 20 and 50 years old." - Anonymous Online Contributor
How many participants are enrolled in this experiment?
"Affirmative. According to clinicaltrials.gov, this research is currently seeking participants with the initial posting date on October 14th 2016 and most recent update on August 5th 2022. The investigators are recruiting a total of 50 individuals from 3 centres." - Anonymous Online Contributor
What therapeutic conditions can be aided by Misoprostol 100Mcg Tab?
"Misoprostol 100Mcg Tab is a commonly prescribed medication for the treatment of missed abortion. Additionally, it can be helpful in addressing cases involving NSAID use, labor induction, and postpartum hemorrhage." - Anonymous Online Contributor
What kind of individuals is this research endeavor seeking?
"Potential applicants must have undergone myomectomy and experienced blood loss during surgery. Additionally, the age range for enrolment is between 20 to 50 years old; at maximum capacity this clinical trial will accept a total of 50 participants." - Anonymous Online Contributor
Can medical professionals attest to the safety of taking Misoprostol 100Mcg Tab?
"Studies have shown Misoprostol 100Mcg Tab to be a safe medical intervention, and thus it has earned the highest score of 3 on our team's evaluation. This is due to this treatment having gained Phase 4 approval." - Anonymous Online Contributor
Are there still opportunities for patients to participate in this research?
"According to the clinicaltrials.gov website, this study is in search of potential participants and has been since October 14th 2016 when it was first published; its most recent update being August 5th 2022." - Anonymous Online Contributor